References Used for the CPFs Educational Content
Recent Research Published in Peer Review Journals
Schraunfnagel, Dean:
Breathing in America: Disease, Progress, and Hope 2010 the American Thoracic Society
Borok, Zea.:
Role of A3 integrin in EMT and Pulmonary Fibrosis; J. Clin. Invest. doi:10.1172/JCI38084.
Uhal, B.D.:
Apoptosos in Pulmonary Fibrosis; Eur Respir Rev 2008; 17: 109, 138–144
Frederick JR, Southerland KW, Fitzpatrick JR, McCormick RC, Blumenthal N, Szeto WY, Pochettino A, Woo YJ.
Impact of Bilateral Lung Transplantation and Cardiopulmonary Bypass on Survival in Patients with Idiopathic Pulmonary Fibrosis. 94th Annual Clinical Congress of the American College of Surgeons. October 14, 2008. Abstract S31S. Tajima, M. Bando, Y. Ishii, T. Hosono, H. Yamasawa, S. Ohno, T. Takada, E. Suzuki, F. Gejyo, and Y. Sugiyama
Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice; Eur. Respir. J., Nov 2008; 32: 1337 - 1343Garantziotis S, Zudaire E, Trempus CS, Hollingsworth JW, Jiang D, Lancaster LH, Richardson E, Zhuo L, Cuttitta F, Brown KK, Noble PW, Kimata K, Schwartz DA. :
Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury; Am J Resp Crit Care, 2008;178:939-47
Srikumar Mallick:
Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit; Respiratory Medicine: Available online 17 July 2008.
Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, Fatenejad S:
Treatment of Idiopathic Pulmonary Fibrosis With Etanercept: An Exploratory, Placebo-Controlled Trial; Am J Respir Crit Care Med. 2008 Jul 31; [Epub ahead of print]; Pubmed ID: 18669816
Vidya Krishnan, MD, MHS; Meredith C. McCormack, MD, MHS; Stephen C. Mathai, MD, MHS; Shikhar Agarwal, MD; Brittany Richardson; Maureen R. Horton, MD; Albert J. Polito, MD; Nancy A. Collop, MD; and Sonye K. Danoff, MD, PhD:
Sleep Quality and Health-Related Quality of Life in Idiopathic Pulmonary Fibrosis; DOI 10.1378/chest.08-0173; Chest published online July 14, 2008
Yuko Waseda, Masahide Yasui, Yoriko Nishizawa, Kanako Inuzuka, Hazuki Takato, Yukari Ichikawa, Atsuro Tagami, Masaki Fujimura and Shinji Nakao:
Angiotensin II Type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice; Respiratory Research 2008, 9:43
Karin M. Vermeulen PhD, Elisabeth M. TenVergert PhD, Erik A.M. Verschuuren MD, PhD, Michiel E. Erasmus MD, PhD and Wim van der Bij MD, PhD;
Pre-transplant Quality of Life Does Not Predict Survival After Lung Transplantation; © 2008 International Society for Heart and Lung Transplantation
Munson, Jeffrey C. MD; Kreider, Mary Elizabeth MD, MS
The Role of Surgical Biopsy in the Evaluation of Interstitial Lung Disease; Clinical Pulmonary Medicine. 15(4):201-209, July 2008.
Xinping Yue, Xian Li, Hong T. Nguyen, Dawn R. Chin, Deborah E. Sullivan§, and Joseph A. Lasky::
Transforming Growth Factor-ί1 Induces Heparan Sulfate 6-O-Endosulfatase 1 Expression in Vitro and in Vivo; J. Biol. Chem., Vol. 283, Issue 29, 20397-20407, July 18, 2008
Barnes PJ (2008):
A blood test
for lung fibrosis? PLoS Med 5(4): e98.
doi:10.1371/journal.
pmed.0050098
PLoS Med 2008:
MMP1 and MMP7
as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis;
Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, et
al.
(2008) PLoS Med 5(4): e93.
doi:10.1371/journal.pmed.0050093
Am J Path (2008): A role for
the receptor for advanced glycation end products in idiopathic pulmonary
fibrosis American Journal of Pathology, 2008; 172(3):583-91; J.M. Englert
& colleagues, UPMC (Pittsburgh, PA)
Radiology: Idiopathic
Pulmonary Fibrosis: Physiologic tests,
quantitative CT indexes, and CT scores as predictors of mortality. Abstract-only. Radiology, 2008;
246(3):935-940). A.C. Best &
colleagues, Univeristy of Colorado (Denver, CO)
Serrano-Mollar A, Nacher M, Gay-Jordi G, Closa D, Xaubet A, Bulbena O. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2007 Dec 15;176(12):1261-8. Epub 2007 Jul 19
Euro Resp J: Pulmonary
Hypertension in patients with pulmonary fibrosis awaiting lung transplant;
abstract-only. European
Respiratory Journal, 2007; 30(4):715-21. A.F. Shorr & colleagues,
Washington Hospital Center (Washington, D.C.)
Am J Respir Crit Care Med:
BUILD-1: A Randomized, Placebo
Controlled Trial of Bsentan in Idiopathic Pulmonary Fibrosis; Abstract-only.
Am J Respir Crit Care Med Vol 177:75-81
Chest 2007: Lung Allocation
Score for Lung Transplantation: Impact
on Disease Severity and Survival; Gries, Mulligan, Edleman, Raghu, Curtis,
Goss. Chest 2007: 132; 1954-1961 DOI:
10.1378/chest.07-1160
Am J Respir Crit Care Med: Role of Alpha
(1)-acid glycoprotein in therapeutic antifibrotic effects of imatinib with
macrolides in mice. Abstract-only. Am J Respir Crit Care Med 2007;
176(12):1243-1250.
Am J Respir Crit Care Med Vol 176 pp 277-284 2007 Mortality from Pulmonary Fibrosis Increased in the United States from 1993-2002 Amy Olsen, M.D., M.S.P.H. National Jewish Medical and Research Center
Am J Respir Crit Care Med Vol 175 pp 1101-1103 2007 Op Ed Taking the "Idio" Out of Idiopathic Pulmonary Fibrosis Author David M. Center, MD, Boston University, Boston, MA
N Engl J Med 2007;356:1317-26. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis: Mary Y. Armanios, M.D., Julian J.-L. Chen, Ph.D., Joy D. Cogan, Ph.D., Jonathan K. Alder, B.A., Roxann G. Ingersoll, B.S., Cheryl Markin, B.S., William E. Lawson, M.D., Mingyi Xie, B.S., Irma Vulto, B.S., John A. Phillips III, M.D., Peter M. Lansdorp, M.D., Ph.D., Carol W. Greider, Ph.D., and James E. Loyd, M.D
Am J Respir Crit Care Med Vol 175. pp 45–54, 2007 Gene Expression Profiling of Familial and Sporadic Interstitial Pneumonia Authors: Ivana V. Yang, Lauranell H. Burch, Mark P. Steele, Jordan D. Savov, John W. Hollingsworth, Erin McElvania-Tekippe, Katherine G. Berman, Marcy C. Speer, Thomas A. Sporn, Kevin K. Brown, Marvin I. Schwarz, and David A. Schwartz
Imre Noth and Fernando J. Martinez; Recent Advances in Idiopathic Pulmonary Fibrosis 2007;132;637-650
Nina M. Patel, David J. Lederer, Alain C. Borczuk and Steven M. Kawut; Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis; Chest 2007;132;998-1006
Respiratory Medicine: Volume 101, Issue 6, June 2007, Pages 1350-1354 Patient experiences with pulmonary fibrosis Collard, Tino, Noble, Shreve, Michaels, Carlson, Schwarz
Selman, Moises and Pardo, Annie: Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis Proc Am Thorac Soc Vol 3. pp 364–372, 2006
J Respir Crit Care Med : Incidence and Prevalence of Idiopathic Pulmonary Fibrosis: Ganesh Raghu, M.D., Derek Weycker, Ph.D., John Edelsberg, M.D., M.P.H., Williamson Z. Bradford, M.D., Ph.D., Gerry Oster, Ph.D.: Published on June 29, 2006 as doi:10.1164/rccm.200602-163OC
D. Jastrzebski, A. Gumola, R. Gawlik, J. Kozielski Dyspnea and Quality of Life in Patients with Pulmonary Fibrosis After Six Weeks of Respiratory Rehabilitation: Journal of Physiology and Pharmacology 2006, 57, Supp 4, 139.148
A Critical Assessment of Treatment Options for Idiopathic Pulmonary Fibrosis: Nirav R. Shah, Paul Noble, Robert M. Jackson, Talmadge E. King, Jr., Steven D. Nathan, MariaPadilla, Ganesh Raghu, Melissa Bruce Rhodes, Marvin Schwarz, Gregory Tino, Robert W. Dubois SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES: 2005; 22: 167-174
Bosentan versus placebo in interstitial lung disease secondary to systemic sclerosis: The BUILD 2 study JR Seibold, CM Black, CP Denton, DE Furst, L Guillevin, LJ Rubin, A Wells, P Charef, S Roux, H Chadha-Boreham: Poster Session at the Annual Meeting of the American Thoracic Society
Interferon gamma 1-b Therapy in Idiopathic Pulmonary Fibrosis*: A Metaanalysis
Ednan K. Bajwa, MD; Najib T. Ayas, MD MPH; Michael Schulzer, MD, PhD; Edwin Mak, BSC; Jay H. Ryu, MD; and Atul Malhotra, MD, FCCP: Chest 2005 128: 203-206
Archives of Internal Medicine June 2005 Vol. 142 Number 12 – The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis: Fernando J. Martinez, MD; Sharon Safrin, MD; Derek Weycker, PhD; Karen M. Starko, MD; Williamson Z. Bradford, MD, PhD; Talmadge E. King Jr., MD; Kevin R. Flaherty, MD; David A. Schwartz, MD; Paul W. Noble, MD; Ganesh Raghu, MD
Journal of Clinical Investigation Vol 114 No. 3 August 2004: Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis: Robert M. Strieter, MD et.al
Journal of Clinical Investigation Vol 114 No. 3 August 2004: Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis: Robert M. Strieter, MD et.al
Zavadil, Jiri & Bottinger, Erwin: TGF-b and epithelial-to-mesenchymal transitions. : Oncogene (2005) 24, 5764–5774
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment (international consensus statement). Am J Respir Crit Care Med . 2000;161:646-664. Gross TJ, Hunninghake, GW. Idiopathic Pulmonary Fibrosis N Engl J Med 2001; 345: 517-525.
A Physician's Guide to Idiopathic Pulmonary Fibrosis.
Stem Cell Statement and Fact Sheet
